$BIIB

$252.26 +$1.57 (0.63%) Close

$BIIB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$BIIB Management Team

Dr. Adam Keeney

Executive Vice President

Head of Corporate Development

Age 48

Compensation -

Sex Male

Ms. Caroline Dorsa

Independent Chairman of the Board

Age 66

Compensation $629.8K USD

Sex Female

Mr. Christopher Viehbacher

President

Chief Executive Officer

Director

Age 65

Compensation $24.17M USD

Sex Male

Ms. Robin Kramer

Chief Financial Officer

Executive Vice President

Age 60

Compensation -

Sex Female

Dr. Ginger Gregory

Chief Human Resources Officer

Executive Vice President

Age 57

Compensation $5.080M USD

Sex Female

Ms. Susan Alexander

Executive Vice President

Chief Legal Officer

Age 68

Compensation $6.506M USD

Sex Female

Dr. Jane Grogan

Executive Vice President

Head of Research

Age 58

Compensation -

Sex Female

Mr. Rachid Izzar

Executive Vice President

Head of Global Product Strategy and Commercialization

Age 50

Compensation $5.448M USD

Sex Male

Ms. Nicole Murphy

Executive Vice President - Pharmaceutical Operations and Technology

Age 52

Compensation $5.740M USD

Sex Female

Dr. Priya Singhal

Executive Vice President

Head of Development

Age 57

Compensation $6.388M USD

Sex Female

Mr. Sean Godbout

Chief Accounting Officer

Vice President

Global Corporate Controller

Principal Accounting Officer

Age 50

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Adam Keeney Executive Vice President Head of Corporate Development	48	-	Male
Ms. Caroline Dorsa Independent Chairman of the Board	66	$629.8K USD	Female
Mr. Christopher Viehbacher President Chief Executive Officer Director	65	$24.17M USD	Male
Ms. Robin Kramer Chief Financial Officer Executive Vice President	60	-	Female
Dr. Ginger Gregory Chief Human Resources Officer Executive Vice President	57	$5.080M USD	Female
Ms. Susan Alexander Executive Vice President Chief Legal Officer	68	$6.506M USD	Female
Dr. Jane Grogan Executive Vice President Head of Research	58	-	Female
Mr. Rachid Izzar Executive Vice President Head of Global Product Strategy and Commercialization	50	$5.448M USD	Male
Ms. Nicole Murphy Executive Vice President - Pharmaceutical Operations and Technology	52	$5.740M USD	Female
Dr. Priya Singhal Executive Vice President Head of Development	57	$6.388M USD	Female
Mr. Sean Godbout Chief Accounting Officer Vice President Global Corporate Controller Principal Accounting Officer	50	-	Male

Board of Directors

From the proxy statement filed Apr 28, 2026

Directors

serving now

Independent

9 of 10

stated in the proxy; 1 not stated

Average tenure

6.3 years

from year joined

CEO also chairs the board

Maria C. Freire

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Maria C. Freire Board chair	71	2021 5 years	Independent	Corporate Governance Committee Compensation and Management Development Committee	Alexandria Real Estate Equities, Inc.	$457,447
Lloyd Minor	68	2024 2 years	Independent	Audit Committee	Caris Life Sciences, Inc.	$439,947
Eric K. Rowinsky	69	2010 16 years	Independent	Corporate Governance Committee Compensation and Management Development Committee	Purple Biotech Ltd.	$454,947
William A. Hawkins	72	2019 7 years	Independent	Audit Committee Corporate Governance Committee	Bioventus, Inc.	$462,447
Menelas Pangalos	59	2025 1 year	Independent	Compensation and Management Development Committee	Absci Corporation	$439,947
Stephen A. Sherwin	77	2010 16 years	Independent	Audit Committee	Neurocrine Biosciences Inc.	$439,947
Susan K. Langer	35	2023 3 years	Independent	Compensation and Management Development Committee	None stated	$439,947
Monish Patolawala	56	2024 2 years	Independent	Audit Committee · Chair	None stated	$447,447
Christopher A. Viehbacher CEO	66	2022 4 years	Not independent	None stated	None stated	Paid as CEO
Jesus B. Mantas	57	2019 7 years	Independent	Compensation and Management Development Committee · Chair	International Flavors and Fragrances Inc.	$459,947
Caroline D. Dorsa Leaving at the meeting	Not stated	Not stated	Not stated	Corporate Governance	None stated	$629,930

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$BIIB Management Team

Dr. Adam Keeney

Ms. Caroline Dorsa

Mr. Christopher Viehbacher

Ms. Robin Kramer

Dr. Ginger Gregory

Ms. Susan Alexander

Dr. Jane Grogan

Mr. Rachid Izzar

Ms. Nicole Murphy

Dr. Priya Singhal

Mr. Sean Godbout

Board of Directors

Related-party transactions

No related-party transactions disclosed